Merck & Co (MRK) returns

Pharmaceuticals · NYSE · Health Care

$149.52 +2.18% Close Oct 30, 2026 Live

Merck returns over 10 years

$1,000 invested in Merck ten years ago was worth $3,613 at the close on October 30, 2026, with dividends reinvested: an average return of 13.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.

MRK, $10,000 investedS&P 500 (SPY)
$10,000$20,000$30,000$40,000
20172019202120232025

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month +2.9% — $1,029 -0.9%
3 months +15.9% — $1,159 +2.1%
Year to date +45.0% — $1,450 +11.7%
1 year +78.4% — $1,784 +12.4%
3 years +59.6% +16.9% $1,596 +88.5%
5 years +97.8% +14.6% $1,978 +76.0%
10 years +261.3% +13.7% $3,613 +316.6%

Merck return by calendar year

YearMRKS&P 500 (SPY)Difference
2026 to date +45.0% +11.7% +33.3%
2025 +9.8% +17.7% -7.9%
2024 -6.3% +24.9% -31.1%
2023 +1.0% +26.2% -25.2%
2022 +49.4% -18.2% +67.6%
2021 +1.7% +28.7% -27.0%
2020 -7.2% +18.4% -25.6%
2019 +22.3% +31.2% -9.0%
2018 +40.0% -4.6% +44.6%
2017 -1.5% +21.7% -23.2%
2016 +15.1% +12.0% +3.1%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: MRK financials · MRK valuation

No forecast, no recommendation. This page describes Merck & Co from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.